|
ATAD2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.038000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.539600E-01 |
| Normal-vs-Stage2 |
5.617200E-01 |
| Normal-vs-Stage3 |
7.167000E-01 |
| Normal-vs-Stage4 |
6.986600E-01 |
| Stage1-vs-Stage2 |
4.202800E-01 |
| Stage1-vs-Stage3 |
9.877800E-01 |
| Stage1-vs-Stage4 |
7.680600E-01 |
| Stage2-vs-Stage3 |
4.444400E-01 |
| Stage2-vs-Stage4 |
4.909200E-01 |
| Stage3-vs-Stage4 |
7.901600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.213800E-01 |
| Normal-vs-AfricanAmerican |
7.191400E-01 |
| Normal-vs-Asian |
4.102600E-01 |
| Caucasian-vs-AfricanAmerican |
6.038800E-01 |
| Caucasian-vs-Asian |
5.521800E-01 |
| AfricanAmerican-vs-Asian |
6.906400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.316800E-01 |
| Normal-vs-Female |
1.617020E-01 |
| Male-vs-Female |
4.948100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.346400E-01 |
| Normal-vs-Extreme_Weight |
3.548200E-01 |
| Normal-vs-Obese |
4.874200E-01 |
| Normal-vs-Extreme_Obese |
4.709200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.744400E-01 |
| Normal_Weight-vs-Obese |
2.322000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.505000E-01 |
| Extreme_Weight-vs-Obese |
7.625600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.703000E-01 |
| Obese-vs-Extreme_Obese |
3.865200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.711250E-01 |
| Normal-vs-Age(41-60Yrs) |
2.344800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.742000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.130200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.109600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.177580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.551500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.559600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.567900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.128800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.116000E-01 |
| Normal-VS-Type2 PRCC |
1.458060E-02 |
| Normal-VS-KIRP CIMP |
6.769400E-01 |
| Normal-VS-Unclassified PRCC |
2.334000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.007330E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.943600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.893600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.834200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.255200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.722200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.823800E-02 |
| Normal-vs-N1 |
1.868840E-01 |
| Normal-vs-N2 |
4.085400E-01 |
| N0-vs-N1 |
2.317900E-02 |
| N0-vs-N2 |
9.494000E-01 |
| N1-vs-N2 |
3.062000E-01 |
|
|
